Literature DB >> 8899050

Basal ganglia and thalamo-cortical hypermetabolism in patients with spasmodic torticollis.

G Galardi1, D Perani, F Grassi, S Bressi, S Amadio, M Antoni, G C Comi, N Canal, F Fazio.   

Abstract

UNLABELLED: The basal ganglia are thought to be involved in the primary dystonias, largely because of the repeated demonstration of neuropathological changes in these nuclei in the secondary dystonias. A hyperactivity of a network involving basal ganglia has been suggested in experimental animal dystonia. To test this hypothesis in humans, we studied the functional correlates of primary cervical dystonia using [18F]FDG and PET.
MATERIAL AND METHODS: Regional cerebral glucose metabolism (rCMRglc) was measured in 10 patients with idiopathic torticollis (6 drug-free and 4 drug-naive) and in 15 normal controls, using 2-[18F]-fluoro-2-deoxy-D-glucose ([18F]FDG) and positron emission tomography (PET).
RESULTS: A significant hypermetabolism in the basal ganglia, thalamus, premotor-motor cortex and cerebellum in the patients compared with normal controls was found. The patients were correctly assigned to their clinical category by a discriminant function analysis with a total accuracy of 96%.
CONCLUSION: The results support the hypothesis that a dysfunction of a subcortical-cortical motor network may play a role in the pathogenesis of focal dystonia, in agreement with the experimental dystonia models.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8899050     DOI: 10.1111/j.1600-0404.1996.tb07049.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  30 in total

Review 1.  Convergent mechanisms in etiologically-diverse dystonias.

Authors:  Valerie B Thompson; H A Jinnah; Ellen J Hess
Journal:  Expert Opin Ther Targets       Date:  2011-12-03       Impact factor: 6.902

2.  Late onset of cervical dystonia in a 39-year-old patient following cerebellar hemorrhage.

Authors:  N Usmani; G S Bedi; C Sengun; A Pandey; C Singer
Journal:  J Neurol       Date:  2010-08-17       Impact factor: 4.849

3.  Defective cerebellar control of cortical plasticity in writer's cramp.

Authors:  Cecile Hubsch; Emmanuel Roze; Traian Popa; Margherita Russo; Ammu Balachandran; Salini Pradeep; Florian Mueller; Vanessa Brochard; Angelo Quartarone; Bertrand Degos; Marie Vidailhet; Asha Kishore; Sabine Meunier
Journal:  Brain       Date:  2013-07       Impact factor: 13.501

4.  Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm.

Authors:  P Roggenkämper; W H Jost; K Bihari; G Comes; S Grafe
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

Review 5.  The functional neuroanatomy of dystonia.

Authors:  Vladimir K Neychev; Robert E Gross; Stephane Lehéricy; Ellen J Hess; H A Jinnah
Journal:  Neurobiol Dis       Date:  2011-02-12       Impact factor: 5.996

6.  Brain positron emission tomography with 2-18F-2-deoxi-D-glucose of patients with dystonia and essential tremor detects differences between these disorders.

Authors:  Vadim Belenky; Andrei Stanzhevsky; Olga Klicenko; Alexandr Skoromets
Journal:  Neuroradiol J       Date:  2017-08-14

7.  What's special about task in dystonia? A voxel-based morphometry and diffusion weighted imaging study.

Authors:  Ritesh A Ramdhani; Veena Kumar; Miodrag Velickovic; Steven J Frucht; Michele Tagliati; Kristina Simonyan
Journal:  Mov Disord       Date:  2014-06-12       Impact factor: 10.338

8.  Abnormal structure-function relationship in spasmodic dysphonia.

Authors:  Kristina Simonyan; Christy L Ludlow
Journal:  Cereb Cortex       Date:  2011-06-10       Impact factor: 5.357

Review 9.  Animal models for dystonia.

Authors:  Bethany K Wilson; Ellen J Hess
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

Review 10.  The focal dystonias: current views and challenges for future research.

Authors:  H A Jinnah; Alfredo Berardelli; Cynthia Comella; Giovanni Defazio; Mahlon R Delong; Stewart Factor; Wendy R Galpern; Mark Hallett; Christy L Ludlow; Joel S Perlmutter; Ami R Rosen
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.